Time trends in cardiac doses in 10,000 patients receiving curative thoracic radiation therapy between 2009 and 2020
Forbes, N. J.; Terrones-Campos, C.; Smith, A.; Reekie, J.; Darkner, S.; Maraldo, M.; Pohl, M.; Risumlund, S.; Specht, L.; Bentzen, S. M.; Petersen, J.; Vogelius, I.
Show abstract
Background and purposeIn the last 20 years, it has become well-documented that incidental cardiac exposure to ionizing radiation is associated with a clinically relevant increased risk of cardiovascular morbidity. In parallel, radiation therapy technologies have been developed to provide target dose coverage with less exposure to adjacent organs at risk. In the current work, we investigate trends in cardiac exposure among patients treated with curative intent radiotherapy from a single institution between 2009 to 2020. Materials and methods10,215 treatment courses were analyzed from 9,966 patients treated with curative intent for intrathoracic or breast cancers in the period 2009-2020. All hearts were re-delineated using an AI model to ensure consistency over time. Cardiac doses were extracted in 3D from the record-and-verify system and converted, voxel-by-voxel, to equi-effective doses in 2 Gy fractions (EQD2) using /{beta}=2 Gy. Mean heart dose (in EQD2) and volume exposed to 5 and 40 Gy (V5 and V40Gy), respectively, were extracted. Time trends in these cardiac dose-volume metrics were investigated for each diagnosis. ResultsPatients with esophageal cancer had the highest mean heart dose (median = 11.67 Gy; IQR = 2.85, 18.18), while the lowest was observed in patients with breast cancer (median = 0.60 Gy; IQR = 0.30, 1.08) and lymphoma (median = 0.01 Gy; IQR = 0.00, 0.38). A decreasing trend over time was seen most clearly for patients with esophageal and lung cancers (p<0.05). Among patients with breast cancer, V40 decreased from 2009-2015 after which we observed an increase. ConclusionThere has been a significant reduction in radiation exposure to the heart in patients treated in the period 2009-2020, likely due to increased awareness of cardiovascular toxicity and technological developments. The study also found a significant increase in V40 from 2015 to 2020 for patients with breast cancers, possibly related to increased prioritization of target coverage. HighlightsO_LI10,215 radiation therapy plans extracted and analyzed C_LIO_LIHearts were re-delineated with machine learning on the therapy CT-scan to ensure time-independent delineations C_LIO_LICardiac doses were found to decrease over time, especially high dose exposure of intrathoracic lesions C_LIO_LIAn unexpected increase in cardiac high dose volume (V40Gy) for breast cancer treatment plans in recent years was observed C_LI
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Normal Tissue Complication Probability (NTCP) prediction model for osteoradionecrosis of the mandible in head and neck cancer patients following radiotherapy: Large-scale observational cohort 96%
- Cluster-Based Toxicity Estimation of Osteoradionecrosis via Unsupervised Machine Learning: Moving Beyond Single Dose-Parameter Normal Tissue Complication Probability by Using Whole Dose-Volume Histograms for Cohort Risk Stratification 95%
- Clinical Impact of Contouring Variability for Prostate Cancer Tumor Boost 95%
Similar papers in this journal
- Personalized volume-deescalated elective nodal irradiation in oropharyngeal squamous cell carcinoma (DeEscO): a study protocol 94%
- Morphological changes after cranial fractionated photon radiotherapy: localized loss of white matter and grey matter volume with increasing dose 94%
- Detection of Alteration in Carotid Artery Volumetry Using Standard-of-care Computed Tomography Surveillance Scans Following Unilateral Radiation Therapy for Early-stage Tonsillar Squamous Cell Carcinoma Survivors: A Cross-Sectional Internally-Matched Carotid Isodose Analysis 93%
Similar papers in this journal
- Evaluation of indirect damage and damage saturation effects in dose-response curves of hypofractionated radiotherapy of early-stage NSCLC and brain metastases 95%
- Dosimetric and biologic intercomparison between electron and proton FLASH beams 95%
- LITE SABR M1: a Phase I Trial of Lattice Stereotactic Body Radiotherapy for Large Tumors 94%
Similar papers in this journal
- Cell lines of the same anatomic site and histologic type show large variability in intrinsic radiosensitivity and relative biological effectiveness to protons and carbon ions 95%
- Evaluation of inverse treatment planning for Gamma Knife radiosurgery using fMRI brain activation maps as organs at risk 95%
- Quality Assurance Assessment of Intra-Acquisition Diffusion-Weighted and T2-Weighted Magnetic Resonance Imaging Registration and Contour Propagation for Head and Neck Cancer Radiotherapy 92%
Similar papers in this journal
- Leveraging intelligent optimization for automated, cardiac-sparing accelerated partial breast treatment planning 96%
- Avasopasem Manganese acts as both a Radioprotector and a Radiomitigator of Radiation-Induced Acute or Late Effects. 93%
- Segmentation stability of human head and neck medical images for radiotherapy applications under de-identification conditions: benchmarking for data sharing and artificial intelligence use-cases 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.